A180 PLACEBO RATES IN MICROSCOPIC COLITIS RANDOMIZED TRIALS: APPLICATIONS FOR FUTURE DRUG DEVELOPMENT USING A HISTORICAL CONTROL ARM

BACKGROUND: There remains a need to develop effective medical therapies for patients with microscopic colitis (MC) who do not respond, are intolerant, or relapse on budesonide. Conducting randomized trials in MC is logistically and ethically challenging: budesonide is highly effective, and therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, P G, Buhler, K, Kaplan, G, Lu, C, Seow, C, Novak, K, Panaccione, R, Ma, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991156/
http://dx.doi.org/10.1093/jcag/gwac036.180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991156/
http://dx.doi.org/10.1093/jcag/gwac036.180

Ejemplares similares